The Faculty of Pain Medicine of the Royal College of Anaesthetists has issued a statement expressing deep concern regarding the planned establishment of independent cannabinoid clinics in the United Kingdom.
The statement follows media reports that the first such clinic is to open in the United Kingdom this week. The Beeches clinic will open in Manchester, offering consultations for approximately £200 and will provide monthly prescriptions for between £600 and £700.
In the statement, Dr Barry Miller, Dean of the Faculty of Pain Medicine said: "The Faculty of Pain Medicine is aware that clinics are being established in the UK by companies with a direct financial interest in cannabinoids, and staffed by doctors, to offer, primarily, cannabis related treatments.”
“The Faculty of Pain Medicine is deeply concerned by this development, which appears in contrast to the very limited data available on the use of cannabinoids for pain management and, that these clinics are being introduced before the findings of research being undertaken by the National Institute for Clinical Excellence are published,” he said.
The Faculty of Pain Medicine said, "it does not support the setting up of pain clinics dedicated to the prescribing of any single substance or intervention".
The statement points out that the Core Standards for Pain Management Services in the UK, which was released in 2015 and endorsed by 12 leading authorities in pain management. The document highlights the need for assessment and management to be provided in a multidisciplinary setting, with consideration given to a patient’s physical and mental well-being.